Vistagen Therapeutics Inc (VTGN) Stock Price, Quote, News & History

VTGNNASDAQ
$0.6301
0.03465.81%
At close: May 19, 5:00 PM EST
$0.6300
-0.0001-0.02%
After Hours: 5:38 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-60.30M
Investing Cash Flow (TTM)
-251.00K
Financing Cash Flow (TTM)
33.21M
Free Cash Flow (TTM)
-60.54M
Capital Expenditure (TTM)
-239.00K
Net Change in Cash (TTM)
-27.34M

Analyst Trends and Forecast

1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$36.75M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
26.70
PB Ratio (TTM)
0.46
Earnings Yield % (TTM)
-319.06%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.29

Company Debt

Total Debt
$379.00K
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$47.37M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-$642.00K

Key Statistics

Open
$0.60
Close
$0.63
Volume / Avg.
859.05K / 766.95K
Day Range
$0.56 - $0.64
52 Wk Range
0.43 - 5.14
Market Cap
$24.96M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
6.33%
Days to Cover
1.55

About

Sector
Health Care
Industry
Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neur...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vistagen Therapeutics (VTGN) stock?

A

You can purchase shares of Vistagen Therapeutics (NASDAQ:VTGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vistagen Therapeutics (VTGN) competitors?

A

There are no as such competitors for Vistagen Therapeutics.

Q

What is the forecast, or price target, for Vistagen Therapeutics (VTGN) stock?

A

Vistagen Therapeutics has a consensus price target of $6.45.

Q

What is the current price for Vistagen Therapeutics (VTGN)?

A

The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $0.63 last updated May 19, 2026 at 5:38 PM EDT.

Q

Does Vistagen Therapeutics (VTGN) pay a dividend?

A

There are no upcoming dividends for Vistagen Therapeutics.

Q

When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?

A

Vistagen Therapeutics does not have any upcoming earnings scheduled.

Q

Is Vistagen Therapeutics (VTGN) going to split?

A

There is no upcoming split for Vistagen Therapeutics.

Q

What sector and industry does Vistagen Therapeutics (VTGN) operate in?

A

Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.